Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-04 08:53 am Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,206,191 2.830% | 1,206,191 (New Position) | View |
| 2022-02-04 08:53 am Sale | 13G | Verve Therapeutics Inc. VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,871,679 3.890% | -623,892 (-25.00%) | View |
| 2021-06-28 08:50 am Purchase | 13G | Verve Therapeutics Inc. VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 2,495,571 5.180% | 2,495,571 (New Position) | View |
| 2020-10-22 10:01 am Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,906,191 5.340% | 1,906,191 (New Position) | View |